<DOC>
	<DOCNO>NCT02456129</DOCNO>
	<brief_summary>This study postmenopausal woman investigate Drug-drug interaction ( DDI ) itraconazole ( ITZ ) orally administer vilaprisan ; absolute bioavailability use intravenous microtracer dose [ 14C ] vilaprisan .</brief_summary>
	<brief_title>Study Postmenopausal Women Investigate Drug-drug Interaction ( DDI ) Between Itraconazole ( ITZ ) Orally Administered Vilaprisan ; Absolute Bioavailability Using Intravenous Microtracer Dose 14CVilaprisan</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Body mass index ( BMI ) : 18 ≤ BMI ≤ 32 kg/m² Postmenopausal state reveal : Medical history , applicable ( natural menopause least 12 month prior first study drug administration ; surgical menopause bilateral ovariectomy least 3 month prior first study drug administration ) , addition : woman &lt; 65 year old , follicle stimulate hormone ( FSH ) &gt; 40 IU/L Incompletely cure preexisting disease assume absorption , distribution , metabolism , elimination effect study drug normal Known suspect liver disease Clinically relevant finding ( e.g . blood pressure , electrocardiogram ( ECG ) ; physical gynecological examination , laboratory examination )</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Clinical Trial , Phase I</keyword>
</DOC>